These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 6125102)

  • 1. Topical medication instillation techniques for glaucoma.
    Xu L; Wang X; Wu M
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD010520. PubMed ID: 28218404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions from timolol administration.
    Van Buskirk EM
    Ophthalmology; 1980 May; 87(5):447-50. PubMed ID: 7402590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
    Feghali JG; Kaufman PL; Radius RL; Mandell AI
    Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timolol-maintenance treatment.
    Calissendorff BM; Marén N
    Acta Ophthalmol (Copenh); 1980 Dec; 58(6):938-46. PubMed ID: 7331780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
    Agarwal HC; Gupta V; Sihota R
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of reported timolol-induced side effects.
    Levine L
    Am J Optom Physiol Opt; 1982 Jun; 59(6):523-8. PubMed ID: 6125102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma.
    Aptel F; Denis P
    Curr Med Res Opin; 2011 Oct; 27(10):1949-58. PubMed ID: 21878000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
    Ormrod D; McClellan K
    Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timolol hemihydrate: a new formulation of timolol for the treatment of glaucoma.
    Stewart WC
    J Ocul Pharmacol Ther; 1996; 12(2):225-37. PubMed ID: 8773937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.
    Cimolai N
    Clin Med Res; 2019 Dec; 17(3-4):90-96. PubMed ID: 31462538
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.